Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID‐19 in Mexico

Chronic kidney disease (CKD) is a recognized public health problem and key determinant of poor health outcomes. In Mexico, this condition has been associated with high and significant risk of death in COVID‐19 patients; however, not enough attention has been given to the vulnerable population as the increasing numbers and fatality rates suggest. This study evaluated the effect of interaction between CKD condition and other risk factors (sex, diabetes, hypertension and obesity) on the survival rate of positive patients for COVID‐19 in Mexico. The results from this study support that CKD patients is a population at high risk for mortality for COVID‐19 and that COVID‐19 positive inpatients with CKD and diabetes are highly vulnerable to death. SUMMARY AT A GLANCE This study evaluated the effect of the interaction of CKD status with other risk factors on the survival rate of COVID‐19‐positive patients in Mexico. The results support that CKD patients are at increased risk of death from COVID‐19, and COVID‐19‐positive CKD and diabetic inpatients are very vulnerable to death.